NEKTAR THERAPEUTICS shareholders Q1 2021

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

NEKTAR THERAPEUTICS shareholders Q1 2021
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 5,707$114,0000.00%
CAPTRUST FINANCIAL ADVISORS 1,625$32,0000.00%
Smithfield Trust Co 224$4,0000.00%
Fieldpoint Private Securities, LLC 25$00.00%
ROYAL BANK OF CANADA 5,509$110,0000.00%
BARCLAYS PLC 17,527$350,0000.00%
Baillie Gifford 1,542$31,0000.00%
Private Capital Group, LLC 67$1,0000.00%
Versant Capital Management, Inc 9$00.00%
Rockefeller Capital Management L.P. 400$8,0000.00%
American Portfolios Advisors 335$6,7000.00%
CWM, LLC 100$2,0000.00%
Geneos Wealth Management Inc. 535$10,0000.00%
North Star Investment Management Corp. 125$2,0000.00%
DEUTSCHE BANK AG\ 27,340$547,0000.00%
Allianz Asset Management GmbH 25,670$513,0000.00%
HARBOUR INVESTMENTS, INC. 313$6,0000.00%
MEEDER ASSET MANAGEMENT INC 61$1,0000.00%
Meridian Wealth Partners, LLC 24$00.00%
PICTET ASSET MANAGEMENT LTD 14,700$294,0000.00%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q1 2021. To view NEKTAR THERAPEUTICS's shareholder history, click here.